QuVa Pharma, Inc. is recalling 648 bags of Oxytocin (30 Units in 500 mL of 0.9% Sodium Chloride Injection) because the product was found to be subpotent and, in some cases, did not contain the drug at all. This prescription medication is used to induce or improve labor contractions during childbirth or to control postpartum bleeding. If you are a healthcare provider or patient who has used this specific lot, please be aware that the lack of active medication may result in ineffective treatment. Consumers should contact their healthcare provider or pharmacist immediately regarding this recall.
The product is subpotent or missing the active ingredient entirely, which means it will not provide the intended therapeutic effect. In a clinical setting, failure of oxytocin to perform as expected can lead to delayed labor or uncontrolled bleeding after delivery, potentially requiring emergency medical intervention.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.